Content Hub
Exclusive Interview with Carla Verissimo, Head of Oncology II, HUB Organoid Technology
-
- The biggest challenges being faced in modelling the TME, effectively assessing efficacy and boosting translational confidence
- Why we are still facing these hurdles
- The next steps the industry must take to overcome them in an exclusive interview